The Ins and Outs of miRNAs as Biomarkers

miRNAs are small noncoding RNAs that control gene expression at the post-transcriptional level. It has been recognized that dysregulation of miRNAs reflects the state and function of cells and tissues, contributing to their dysfunction. The identification of hundreds of extracellular miRNAs in biolo...

Повний опис

Збережено в:
Бібліографічні деталі
Формат: Online
Мова:Англійська
Опубліковано: MDPI - Multidisciplinary Digital Publishing Institute 2023
Предмети:
Онлайн доступ:ONIX_20230714_9783036579252_47
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
_version_ 1869514618080067584
collection Directory of Open Access Books
description miRNAs are small noncoding RNAs that control gene expression at the post-transcriptional level. It has been recognized that dysregulation of miRNAs reflects the state and function of cells and tissues, contributing to their dysfunction. The identification of hundreds of extracellular miRNAs in biological fluids has underscored their potential in the field of biomarker research. In addition, the therapeutic potential of miRNAs is receiving increasing attention in numerous conditions. On the other hand, many operational issues, including stability, delivery systems, and bioavailability, have yet to be resolved. In this dynamic field, biopharmaceutical companies are increasingly engaged, and ongoing clinical trials point to anti-miR and miR-mimic molecules as novel classes of molecules for upcoming therapeutic applications. This reprint aims to provide a broad overview of current knowledge on several outstanding issues and new opportunities offered by miRNAs in the treatment of diseases and as early diagnostic tools for next-generation medicine.
format Online
id doab-20.500.12854ir-101348
institution Directory of Open Access Books
language eng
publishDate 2023
publishDateRange 2023
publishDateSort 2023
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-1013482024-03-28T03:33:11Z The Ins and Outs of miRNAs as Biomarkers Iacomino, Giuseppe Lauria, Fabio mi-RNA physical exercise gene expression stress head and neck cancer miRNA chemoresistance protocol systematic review hazard ratio patient survival up-regulation down-regulation microRNA circulating miRNA theranostic biomarkers chemosensitivity melanoma meta-analysis miRNAs microRNAs liver neoplasms angiogenesis cancer biomarkers transfection qRT-PCR plasma amplification efficiency EBV LMP1 nasopharyngeal cells expression profiling chronic low-grade inflammation inflammation-associated biomarkers overweight and obesity children/adolescents sex-related associations DNA copy number variation comparative study progenitor cells amniotic fluid leiomyoma myometrium divergent cell commitment linear dysregulation circulating microRNAs extracellular miRNA nasopharyngeal carcinoma miRNA-based diagnosis HNSCC tumor-suppressor miR-30e-5p FOXD1 TCGA cervical cancer non-coding RNAs diagnosis prognosis therapeutics regulation of gene expression alveolar epithelial type II cells type II pneumocytes ATII AECII flow cytometry autofluorescence pathway analysis TGF-beta homeostasis EMT RNA-based therapeutic personalized medicine translational medicine breast cancer diagnostics therapy response hepatitis C virus liver injury microRNA-192 microRNA-29a HCV genotype-3 thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PS Biology, life sciences miRNAs are small noncoding RNAs that control gene expression at the post-transcriptional level. It has been recognized that dysregulation of miRNAs reflects the state and function of cells and tissues, contributing to their dysfunction. The identification of hundreds of extracellular miRNAs in biological fluids has underscored their potential in the field of biomarker research. In addition, the therapeutic potential of miRNAs is receiving increasing attention in numerous conditions. On the other hand, many operational issues, including stability, delivery systems, and bioavailability, have yet to be resolved. In this dynamic field, biopharmaceutical companies are increasingly engaged, and ongoing clinical trials point to anti-miR and miR-mimic molecules as novel classes of molecules for upcoming therapeutic applications. This reprint aims to provide a broad overview of current knowledge on several outstanding issues and new opportunities offered by miRNAs in the treatment of diseases and as early diagnostic tools for next-generation medicine. 2023-07-14T14:26:00Z 2023-07-14T14:26:00Z 2023 book ONIX_20230714_9783036579252_47 9783036579252 9783036579245 https://directory.doabooks.org/handle/20.500.12854/101348 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/7443 https://mdpi.com/books/pdfview/book/7443 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-7924-5 10.3390/books978-3-0365-7924-5 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036579252 9783036579245 254 Basel open access
spellingShingle mi-RNA
physical exercise
gene expression
stress
head and neck cancer
miRNA
chemoresistance
protocol
systematic review
hazard ratio
patient survival
up-regulation
down-regulation
microRNA
circulating miRNA
theranostic biomarkers
chemosensitivity
melanoma
meta-analysis
miRNAs
microRNAs
liver neoplasms
angiogenesis
cancer biomarkers
transfection
qRT-PCR
plasma
amplification efficiency
EBV
LMP1
nasopharyngeal cells
expression profiling
chronic low-grade inflammation
inflammation-associated biomarkers
overweight and obesity
children/adolescents
sex-related associations
DNA copy number variation
comparative study
progenitor cells
amniotic fluid
leiomyoma
myometrium
divergent cell commitment
linear dysregulation
circulating microRNAs
extracellular miRNA
nasopharyngeal carcinoma
miRNA-based diagnosis
HNSCC
tumor-suppressor
miR-30e-5p
FOXD1
TCGA
cervical cancer
non-coding RNAs
diagnosis
prognosis
therapeutics
regulation of gene expression
alveolar epithelial type II cells
type II pneumocytes
ATII
AECII
flow cytometry
autofluorescence
pathway analysis
TGF-beta
homeostasis
EMT
RNA-based therapeutic
personalized medicine
translational medicine
breast cancer
diagnostics
therapy response
hepatitis C virus
liver injury
microRNA-192
microRNA-29a
HCV genotype-3
thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences
The Ins and Outs of miRNAs as Biomarkers
title The Ins and Outs of miRNAs as Biomarkers
title_full The Ins and Outs of miRNAs as Biomarkers
title_fullStr The Ins and Outs of miRNAs as Biomarkers
title_full_unstemmed The Ins and Outs of miRNAs as Biomarkers
title_short The Ins and Outs of miRNAs as Biomarkers
title_sort ins and outs of mirnas as biomarkers
topic mi-RNA
physical exercise
gene expression
stress
head and neck cancer
miRNA
chemoresistance
protocol
systematic review
hazard ratio
patient survival
up-regulation
down-regulation
microRNA
circulating miRNA
theranostic biomarkers
chemosensitivity
melanoma
meta-analysis
miRNAs
microRNAs
liver neoplasms
angiogenesis
cancer biomarkers
transfection
qRT-PCR
plasma
amplification efficiency
EBV
LMP1
nasopharyngeal cells
expression profiling
chronic low-grade inflammation
inflammation-associated biomarkers
overweight and obesity
children/adolescents
sex-related associations
DNA copy number variation
comparative study
progenitor cells
amniotic fluid
leiomyoma
myometrium
divergent cell commitment
linear dysregulation
circulating microRNAs
extracellular miRNA
nasopharyngeal carcinoma
miRNA-based diagnosis
HNSCC
tumor-suppressor
miR-30e-5p
FOXD1
TCGA
cervical cancer
non-coding RNAs
diagnosis
prognosis
therapeutics
regulation of gene expression
alveolar epithelial type II cells
type II pneumocytes
ATII
AECII
flow cytometry
autofluorescence
pathway analysis
TGF-beta
homeostasis
EMT
RNA-based therapeutic
personalized medicine
translational medicine
breast cancer
diagnostics
therapy response
hepatitis C virus
liver injury
microRNA-192
microRNA-29a
HCV genotype-3
thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences
topic_facet mi-RNA
physical exercise
gene expression
stress
head and neck cancer
miRNA
chemoresistance
protocol
systematic review
hazard ratio
patient survival
up-regulation
down-regulation
microRNA
circulating miRNA
theranostic biomarkers
chemosensitivity
melanoma
meta-analysis
miRNAs
microRNAs
liver neoplasms
angiogenesis
cancer biomarkers
transfection
qRT-PCR
plasma
amplification efficiency
EBV
LMP1
nasopharyngeal cells
expression profiling
chronic low-grade inflammation
inflammation-associated biomarkers
overweight and obesity
children/adolescents
sex-related associations
DNA copy number variation
comparative study
progenitor cells
amniotic fluid
leiomyoma
myometrium
divergent cell commitment
linear dysregulation
circulating microRNAs
extracellular miRNA
nasopharyngeal carcinoma
miRNA-based diagnosis
HNSCC
tumor-suppressor
miR-30e-5p
FOXD1
TCGA
cervical cancer
non-coding RNAs
diagnosis
prognosis
therapeutics
regulation of gene expression
alveolar epithelial type II cells
type II pneumocytes
ATII
AECII
flow cytometry
autofluorescence
pathway analysis
TGF-beta
homeostasis
EMT
RNA-based therapeutic
personalized medicine
translational medicine
breast cancer
diagnostics
therapy response
hepatitis C virus
liver injury
microRNA-192
microRNA-29a
HCV genotype-3
thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences
url ONIX_20230714_9783036579252_47